PMID: 9436463Jun 1, 1997Paper

Solid phase IL-2-IL-2R alpha assay with time resolved fluorometry

Immunology Letters
K StenroosC Lindqvist

Abstract

A time-resolved fluorometric, solid phase, receptor ligand interaction assay is described. The assay consists of wells coated with anti-human IL-2 receptor alpha (hIL-2R alpha) monoclonal antibodies (mAb), europium labelled hIL2 (Eu-IL-2) and human recombinant IL-2 receptor alpha subunits expressed in the baculovirus expression vector system (BEVS). In the assay hIL-2R alpha-Eu-IL-2 complexes bind to the solid phase mAb. Receptor bound Eu is dissociated into an enhancer solution where it forms highly fluorescent complexes. The fluorescence is measured in a time-resolved fluorometer. The Kd value calculated from the saturation curve is in good agreement with previously reported values for the low affinity type of IL-2R, making the described assay a simple and nonradioactive alternative for measurement of soluble hIL-2R alpha in biological systems. Furthermore this assay format provides convenient separation of bound ligand from unbound and is therefore suitable for high throughput screenings.

References

Jul 17, 1992·Science·T TakeshitaK Sugamura
May 28, 1981·Nature·C S HenneyS Gillis
Mar 1, 1984·Analytical Biochemistry·I HemmiläT Lövgren
Oct 1, 1983·The Journal of Experimental Medicine·R J Robb, W C Greene
Dec 1, 1981·Molecular Immunology·R J Robb, K A Smith
Sep 1, 1993·Scandinavian Journal of Immunology·C LindqvistC Oker-Blom

❮ Previous
Next ❯

Citations

May 17, 2005·Life Sciences·Heather L Handl, Robert J Gillies

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.